Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: porcelain gallbladder and end-stage liver disease major surgical or invasive procedure: subtotal cholecystectomy history of present illness: from operative report : "mr. is a very pleasant 53- year-old gentleman with end-stage liver disease, currently child's b/b- cirrhotic, who is attempting to complete his workup for the liver transplant list. during the process of his evaluation he was noted have a porcelain gallbladder with significant stones within the gallbladder itself. based upon our concern for a gallbladder malignancy we did not believe that he would be a suitable candidate for listing for transplantation without cholecystectomy to ensure that there was no malignancy within the wall of the gallbladder." past medical history: # alcoholic cirrhosis --portal hypertension --tips (): tips revisions x 3 --not currently listed given severe obesity # dm2, insulin dependent (hba1c 6.2% 6/07) # obesity # rhinoplasty, s/p broken nose as a teenager # squamous cell skin ca @ l shoulder, removed # obstructive sleep apnea: bipap --pulmonary arterial hypertension osa social history: # personal: married, living in # tobacco: 16-pack-year h/o smoking, quit 27 years ago # alcohol: h/o alcohol abuse, quit 10 years ago # recreational drugs: remote marijuana use, no h/o ivdu # employment: unemployed. former food/beverage director in hotel and cruise industry. family history: # mother, d 56: cva # father, d 83: alzheimer's # sister: dm2, seizures # brother, older: disease # brother, younger: known disease physical exam: on discharge: gen: nad, a&ox3 cv: rrr lungs: ctab abd: soft, approp tender, mild distension, obese 2 jp drains in place - insertion sites clean and dry ext: 1+ edema pertinent results: on admission: 02:33pm wbc-4.3# rbc-3.09* hgb-10.3* hct-29.7* mcv-96 mch-33.3* mchc-34.8 rdw-17.6* fibrinoge-261 11:10am pt-16.1* ptt-32.5 inr(pt)-1.5* 11:10am plt count-92*# 11:30am glucose-158* lactate-1.7 na+-135 k+-5.3 cl--109 11:30am ascites wbc-0 rbc-* polys-11* lymphs-44* monos-19* mesotheli-10* other-16* 11:30am glucose-158* lactate-1.7 na+-135 k+-5.3 cl--109 on discharge: wbc-2.2* rbc-2.72* hgb-9.1* hct-25.6* mcv-94 mch-33.4* mchc-35.4* rdw-18.1* plt ct-44* glucose-280* urean-66* creat-1.7* na-131* k-3.9 cl-98 hco3-24 angap-13 alt-24 ast-26 alkphos-113 totbili-2.7* albumin-3.0* brief hospital course: 53 yo m with the above history underwent subtotal ccy on . postop he was admitted to the sicu coagulopathy. he was transfused 4u platelets, 1u prbc's, 10 & 5 units iv insulin given for hyperkalemia. started on insulin gtt @13. tx'd to floor on . was consulted for management of blood glucose. transfused 2u platelets on . insulin gtt was d/c'd, and then restarted 12 hours later to keep blood sugars 140-200's. on , he was transfused 1u prbc's and 1u platelets. physical therapy was consulted and followed the patient. on , he had a ct to rule out any hematoma or any cause for concern given the platelet requirements, which showed no hematoma or bleeding. insulin gtt was d/c'd on , and patient was titrated back up to his home dose of nph (45u ). on the day of discharge, the patient is doing well, afebrile, avss, hct stable at 25.6, plts 44, asymptomatic, tolerating po, ambulating halls without difficulty, pain well-controlled. he is a known patient to , and he will make a follow-up appointment with them as outpt. medications on admission: mg oxide 400gm'', spironolactone 200mg qam/100mg qhs, lasix 80'', xifaxan 600mg , humulin 45u , humalog ss, lactulose 1 tab po bid discharge medications: 1. lactulose 10 g/15 ml solution sig: thirty (30) ml po bid (2 times a day). 2. rifaximin 200 mg tablet sig: three (3) tablet po bid (2 times a day). 3. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) for 1 months. disp:*60 capsule(s)* refills:*2* 4. magnesium oxide 400 mg tablet sig: one (1) tablet po bid (2 times a day). 5. furosemide 40 mg tablet sig: two (2) tablet po bid (2 times a day). 6. spironolactone 100 mg tablet sig: two (2) tablet po daily (daily). 7. spironolactone 100 mg tablet sig: one (1) tablet po daily18 (once daily @ 1800). 8. oxycodone 5 mg tablet sig: one (1) tablet po q4h (every 4 hours) as needed for 2 weeks. disp:*30 tablet(s)* refills:*0* 9. iss continue your home insulin sliding scale and resume home dose of nph. call your provider to make an appointment. discharge disposition: home discharge diagnosis: end-stage liver disease, porcelain gallbladder discharge condition: stable discharge instructions: please call dr. office if you have pain, bleeding, redness, chest pain, shortness of breath, bloody stool, or nausea/vomiting. call if you have any concerns or questions. followup instructions: 1) please call dr. office to confirm a follow-up appointment (discussed with patient - he will be seen in clinic on monday ) 2) ultrasound phone: 1:45 3) , md phone: 3:40 4) pulmonary breathing tests phone: 10:40 procedure: transfusion of packed cells transfusion of platelets other cholecystotomy other partial cholecystectomy diagnoses: hyperpotassemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled alcoholic cirrhosis of liver personal history of tobacco use personal history of other malignant neoplasm of skin unspecified sleep apnea primary pulmonary hypertension morbid obesity family history of ischemic heart disease varices of other sites other and unspecified coagulation defects other specified disorders of gallbladder family history of diabetes mellitus 

Answer: The patient is high likely exposed to